<img alt="" height="1" width="1" />
US approves Acorda MS drug to help with walking
Reuters
WASHINGTON, Jan 22 (Reuters) - Acorda Therapeutics Inc (ACOR.O) won US approval on Friday for the first drug to improve walking ability in patients with multiple sclerosis. Patients in clinical trials who took the oral drug, Ampyra, had faster walking ...
FDA OKs Ampyra To Improve Walking In Adults With Multiple SclerosisWall Street Journal
FDA approves Elan's AmpyraDrug Store News (blog)
FDA Approves Ampyra to Improve Walking in Adults with Multiple SclerosisPR Newswire (press release)
CanadianBusiness.com
all 19 news articles »
More...